Home › Nasopharyngeal Carcinoma › Washington
Nasopharyngeal Carcinoma clinical trials in Washington, DC
3 studies for Nasopharyngeal Carcinoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
RecruitingPhase 2
- Children's National Medical Center, Washington D.C.
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- George Washington University Medical Center, Washington D.C.
Nasopharyngeal Carcinoma trials in other cities
- Atlanta, GA6 studies
- Houston, TX3 studies
- Pittsburgh, PA3 studies
- Los Angeles, CA3 studies
- Cincinnati, OH3 studies
- Richmond, VA3 studies
- Charlotte, NC3 studies
- San Francisco, CA3 studies
- Milwaukee, WI3 studies
- Chicago, IL3 studies
- Oklahoma City, OK3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.